LONDON--(BUSINESS WIRE)--RepRegen, the ‘smart biomaterials’ company, welcomed His Royal Highness, Prince Andrew, Duke of York to its headquarters earlier today, where he met with CEO Mr. Ian Brown and CSO Professor Molly Stevens and learned about RepRegen’s commercialization plans for StronBone in Europe and the U.S.